Interleukin-8 (IL-8), systematically termed CXCL8, is a potent chemotactic cytokine of the CXC chemokine family that functions as the primary recruitment signal for neutrophils to sites of tissue damage, infection, or inflammation. It is rapidly synthesized (within minutes to hours) by macrophages, epithelial cells, endothelial cells, and muscle tissue in response to inflammatory stimuli, serving dual roles as both a damage-response coordinator in acute inflammation and a metabolic signaling myokine released during exercise.
Think of IL-8 as an emergency flare gun fired from the site of an accident. When tissue damage or infection occurs, cells at the scene (macrophages, epithelial cells, endothelium) immediately shoot red flares into the bloodstream — this is IL-8. The flares create a visible gradient: brighter closer to the source, dimmer further away. Neutrophils circulating in the blood are like emergency responders trained to follow flare intensity — they see the glow, swim up the gradient (chemotaxis), and converge on the accident site within hours. The flare doesn't just attract responders; it also primes them to arrive ready for battle — activating their weapons (respiratory burst), making them sticky to blood vessel walls (adhesion molecules), and preparing their explosive charges (degranulation). This same flare can be fired during exercise from contracting muscle — not because of damage, but as a metabolic "all-clear" signal that coordinates tissue remodeling and energy distribution. Context determines meaning: flare at an infection = neutrophil assault; flare during a workout = metabolic coordination.
IL-8 production is triggered through multiple pathogen and damage recognition pathways:
Upstream Activation:
Secretion and Gradient Formation:
- IL-8 secreted as 72-77 amino acid protein (8-10 kDa)
- Forms concentration gradient from source (injury/infection site) to blood
- Stable in extracellular matrix (half-life ~2-4 hours), allowing sustained gradient
Receptor Binding and Neutrophil Activation:
graph TD
A[IL-8 in gradient] --> B[CXCR1 receptor on neutrophil]
A --> C[CXCR2 receptor on neutrophil]
B --> D[G-protein signaling cascade]
C --> D
D --> E[PLC activation]
E --> F["IP3 + DAG production"]
F --> G["Ca²⁺ release"]
G --> H1[Chemotaxis - actin polymerization]
G --> H2[Degranulation - granule release]
G --> H3[Respiratory burst - NADPH oxidase]
G --> H4["Adhesion - β2-integrin expression"]
D --> I[PI3K/Akt pathway]
I --> J["Cell survival + migration"]
Detailed Receptor Signaling:
- CXCR1 and CXCR2 are G-Protein Receptors (Gαi-coupled)
- IL-8 binding → GTP replaces GDP on Gα subunit → dissociation of Gβγ
- Gβγ → activates phospholipase C-β (PLC-β) → cleaves PIP2 to IP3 + DAG
- IP3 → binds endoplasmic reticulum receptors → Ca²⁺ release (from 100 nM to 1-5 μM cytoplasmic)
- DAG + Ca²⁺ → activates PKC → phosphorylates cytoskeletal proteins (chemotaxis)
- Simultaneously: Gαi inhibits adenylyl cyclase → reduces cAMP → disinhibition of inflammatory responses
- PI3K/AKT pathway → promotes neutrophil survival and directional migration
Neutrophil Functional Responses:
- Chemotaxis: Actin polymerization at leading edge, myosin contraction at rear → migration speed 10-20 μm/min
- Adhesion: Upregulation of β2-integrins (LFA-1, Mac-1) → bind ICAM-1 and VCAM-1 on endothelium
- Respiratory burst: NADPH oxidase assembly → produces superoxide (O2⁻) and hydrogen peroxide (H2O2)
- Degranulation: Release of azurophilic granules (myeloperoxidase, elastase) and specific granules (lactoferrin, collagenase)
Muscle-Derived IL-8 During Exercise:
- Muscle contraction → metabolic stress + mechanical stretch → NF-κB activation
- IL-8 released from myocytes (10-100 pg/mL increase in circulation)
- Acts locally: promotes angiogenesis via VEGF upregulation, coordinates tissue repair
- Acts systemically: contributes to metabolic flexibility, lipolysis coordination
Angiogenic Functions:
- IL-8 → binds CXCR2 on endothelial cells → activates ERK1-2 and Akt
- Upregulates VEGF, MMP-2, MMP-9 → basement membrane degradation
- Promotes endothelial cell migration and tube formation → neovascularization (critical in wound healing and cancer progression)
Acute Inflammation and Wound Healing:
IL-8 is the primary coordinator of the neutrophilic phase of acute inflammation. In healthy wound healing, IL-8 levels increase approximately 2-fold above baseline within 24-48 hours, establishing the initial inflammatory infiltrate that clears debris and pathogens. This is an adaptive response — neutrophils arrive, clear damage, and IL-8 production ceases as resolution begins (see SPMs, resolvins). Clinical implication: early IL-8 elevation in wounds is normal and necessary; persistent elevation beyond 5-7 days suggests failed resolution or secondary infection.
Exercise and Metabolic Signaling:
As a myokine, muscle-derived IL-8 during physical activity reflects hormetic stress — the muscle's adaptive response to contraction. Unlike inflammation-driven IL-8 (which co-occurs with TNF-α, IL-1β, and pain), exercise-induced IL-8 occurs in a low-inflammatory context with concurrent anti-inflammatory signals (IL-10, IL-6). This context-dependency is critical in cPNI: the same molecule signals damage in one context and adaptation in another. Intervention: distinguish IL-8 in sedentary, inflamed patients (pathological) from IL-8 in exercising patients (adaptive).
Chronic Elevation — Pathological States:
Persistent IL-8 elevation (>10 pg/mL baseline, >50 pg/mL in serum) indicates:
Neutrophil Recruitment Synergies:
IL-8 works in concert with CXCL1 (another neutrophil chemoattractant). Together, they amplify neutrophil migration by creating overlapping gradients. Clinical significance: blocking IL-8 alone may be insufficient in hyperinflammatory states; both chemokines must be addressed.
Selfish Immune System Context:
IL-8-driven neutrophil recruitment is a prioritization decision by the immune system. In chronic inflammation, the immune system may "selfishly" maintain neutrophil recruitment to perceived ongoing threat (real or sterile), even when this damages host tissue (e.g., rheumatoid joint destruction). This aligns with allostatic load: the cost of persistent IL-8 signaling is collateral tissue damage. Intervention approach: address upstream drivers (DAMPs, microbial translocation, psychological stress activating NF-κB) rather than merely suppressing IL-8.
Biomarker Use:
- Acute infections: IL-8 >20 pg/mL in serum suggests bacterial infection (more specific than CRP for bacterial vs viral)
- ARDS and sepsis: IL-8 >100 pg/mL in bronchoalveolar lavage predicts poor outcome
- Cancer: Serum IL-8 >50 pg/mL associated with advanced stage and poor prognosis
- IBD flares: Fecal IL-8 >50 ng/g indicates active mucosal inflammation
Intervention Implications:
- Primary neutrophil chemoattractant; creates concentration gradient for directional migration (chemotaxis)
- Approximately 2-fold elevation during normal wound healing (evidence from Module 5)
- Binds CXCR1 (high affinity) and CXCR2 (lower affinity but broader expression) on neutrophils and endothelial cells
- Rapid production: mRNA detectable within 15 minutes of stimulus; protein secreted by 30-60 minutes
- Molecular weight: 8-10 kDa (72-77 amino acids); N-terminal ELR motif critical for receptor binding
- Serum baseline in healthy adults: <5-10 pg/mL; acute infection: 20-100 pg/mL; severe sepsis: >100 pg/mL
- Released by macrophages, epithelial cells, endothelial cells, fibroblasts, keratinocytes, and muscle cells during contraction
- Synergizes with CXCL1 (GRO-α) for maximal neutrophil recruitment
- Promotes angiogenesis via CXCR2 on endothelial cells → critical in wound healing and cancer vascularization
- Chronic elevation linked to poor prognosis in breast cancer, lung cancer, melanoma (drives metastatic niche formation)
- Exercise-induced IL-8 peaks at 30-60 minutes post-exercise, returns to baseline by 2-3 hours
- Inhibited by resolution mediators: resolvins, protectins, maresins (via GPR-mediated feedback on NF-κB)
- Half-life in circulation: 2-4 hours (longer in tissue gradients due to matrix binding)
- Genetic polymorphisms in IL-8 promoter (−251 A/T) associated with increased production and higher cancer risk
- neutrophils — primary target cell; IL-8 is the dominant chemoattractant directing neutrophil migration from blood to tissue
- CXCR1 — high-affinity G-protein coupled receptor mediating chemotaxis, respiratory burst, and degranulation
- CXCR2 — broader-expressed IL-8 receptor on neutrophils, endothelial cells, and tumor cells; mediates angiogenesis
- CXCL1 — synergistic chemokine; together with IL-8 creates amplified neutrophil recruitment gradient
- wound healing — IL-8 elevated ~2x in early inflammatory phase; coordinates neutrophil-mediated debris clearance
- myokine — released from contracting muscle as part of adaptive exercise response; context-dependent anti-inflammatory role
- exercise — muscle contraction induces IL-8 secretion (10-100 pg/mL increase); promotes angiogenesis and metabolic adaptation
- TNF-α — upstream inducer of IL-8 via TNFR → NF-κB pathway; co-elevated in inflammatory states
- IL-1β — synergistic inducer of IL-8; both activate NF-κB in macrophages and epithelial cells
- IL-6 — co-released myokine during exercise; contrasts with IL-8's dual inflammatory/adaptive roles
- NF-κB — master transcription factor activated by PAMPs, DAMPs, cytokines; directly induces IL-8 gene transcription
- macrophages — major cellular source of IL-8 in response to pathogens, DAMPs, and inflammatory cytokines
- endothelial cells — produce IL-8 upon activation; upregulate adhesion molecules (ICAM-1, VCAM-1) for neutrophil transmigration
- acute inflammation — IL-8 establishes the initial neutrophilic infiltrate within 4-24 hours of injury or infection
- chronic inflammation — persistent IL-8 elevation indicates unresolved inflammation; drives tissue damage in RA, IBD, COPD
- angiogenesis — IL-8 binds CXCR2 on endothelial cells → VEGF upregulation, tube formation; critical in healing and cancer
- cancer — elevated IL-8 (>50 pg/mL) promotes tumor vascularization, metastatic niche formation, and immunosuppression
- respiratory burst — IL-8 activates NADPH oxidase in neutrophils → superoxide and H2O2 production for pathogen killing
- tissue repair — coordinates early inflammatory phase; must be terminated for resolution to proceed (via SPMs)
- PAMPs — bacterial LPS, viral RNA trigger TLR activation → NF-κB → IL-8 production within minutes
- DAMPs — HMGB1, ATP, hyaluronan fragments from tissue damage activate NLRP3 inflammasome → IL-1β → IL-8
- resolvins — RvD1, RvE1 terminate IL-8 production via GPR-mediated inhibition of NF-κB; mark resolution phase
- gut permeability — increased intestinal permeability → bacterial translocation → LPS-driven IL-8 production systemically
- metabolic flexibility — muscle-derived IL-8 during exercise contributes to metabolic signaling and lipolysis coordination
- rheumatoid arthritis — chronically elevated synovial IL-8 drives neutrophil infiltration → cartilage and bone destruction
- VEGF — IL-8 upregulates VEGF in endothelial cells and tumors; both coordinate neovascularization
- matrix metalloproteinases (MMPs) — IL-8 induces MMP-2 and MMP-9 secretion; facilitates neutrophil extravasation and angiogenesis
- cortisol — glucocorticoids suppress IL-8 transcription via GR-mediated NF-κB inhibition; cortisol resistance allows unchecked IL-8
- vitamin D — VDR activation inhibits NF-κB → reduced IL-8; deficiency associated with higher IL-8 in inflammatory diseases
- omega-3 fatty acids — EPA/DHA substrate for resolvins that inhibit IL-8; supplement to shift from IL-8 production to resolution
- Module 5 — wound healing, IL-8 elevation approximately 2x during healing responses
- Module 10 — myokines, muscle-derived IL-8 during physical activity and metabolic signaling